Aclid
New York
About Aclid
Aclid is a biotechnology security and compliance automation platform. Aclid is used by gene synthesis companies to verify customers, screen DNA and RNA orders for pathogenic and hazardous elements, and automate compliance inspections.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.3M
- Funding stage: Seed
- Last round: Seed (Jun 2023)
- Website: aclid.bio
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/aclid-9335 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.